1. 2335 Analysis of activity, efficacy and safety of first line Nab Paclitaxel (Nab-P) and Gemcitabine (G) in advanced pancreatic cancer (APDAC) frail and elderly patients (pts). (September 2015) Authors: Giordano, G.; De Vita, F.; Melisi, D.; Vaccaro, V.; Zaniboni, A.; Zagonel, V.; Vasile, E.; Passardi, A.; Leo, L.; Ventriglia, J.; Marciano, R.; Russano, M.; Conca, R.; Andreozzi, F.; Lucchini, E.; Musettini, G.; Bertocchi, P.; Bergamo, F.; Milella, M.; Febbraro, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗